CDX Medical launches first COMPACT ECMO pump
CDXals breakthrough system enables patient mobility and expands ECMO access beyond traditional ICU environments
CDX Medical Technologies unveils CDXals, a breakthrough in extracorporeal life support. Designed for patient mobility, simplified setup, and rapid deployment, CDXals marks the first truly compact axial ECMO system that can scale beyond traditional ICU environments.
Expanding Patient Access
By enabling use in acute and chronic respiratory cases, including ARDS, COPD, and transplant recovery, CDXals opens access to over 370,000 patients annually who are underserved by existing ECMO technology.
Addressing Critical Barriers
This innovation addresses long-standing barriers in cost, complexity, and training by offering a streamlined, portable system built for today's pulmonary care needs.
Key Features:
- Patient Mobility: First compact design enabling patient movement during therapy
- Simplified Setup: Streamlined deployment process reducing complexity
- Rapid Deployment: Quick activation for emergency and planned procedures
- Scalable Platform: Extends beyond ICU to multiple care environments
Clinical Applications
CDXals is designed to support a broad range of respiratory conditions:
- ARDS (Acute Respiratory Distress Syndrome): Critical care support for severe lung injury
- COPD: Advanced support for chronic obstructive pulmonary disease exacerbations
- Transplant Recovery: Post-operative respiratory support during lung transplant recovery
- Bridge Therapy: Temporary support while awaiting definitive treatment
Market Impact
The CDXals system represents a paradigm shift in ECMO technology, making life-saving respiratory support accessible to a significantly larger patient population through its innovative compact design and simplified operation.